Influenza-related mortality: Considerations for practice and public health

JAMA

Volumn 289, Issue 2, 2003, Pages 227-229

  Morens, David M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

RESPIRATORY SYNCYTIAL VIRUS VACCINE;

AGE; AGED; AGING; CALCULATION; CAUSE OF DEATH; EDITORIAL; HIGH RISK POPULATION; HUMAN; IMMUNITY; INFECTION RESISTANCE; INFLUENZA; MEDICAL PRACTICE; MORTALITY; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RISK FACTOR; STATISTICAL MODEL; VIRUS RESISTANCE;

EID: 0037425514     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.289.2.227     Document Type: Editorial

References (18)

1. Thompson WW, Shay DK, Weintraub E, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289:179-186.
2. Brammer TL, Murray EL, Fukuda K, et al. Surveillance for influenza - United States, 1997-98,1998-99, and 1999-00 seasons. MMWR Morb Mortal Wkly Rep. 2002;51(SS07):1-10.
3. Falsey AR, Walsh EE. Respiratory syncytial virus infection in adults. Clin Microbiol Rev. 2000;13:371-384.
4. Glezen WP, Greenberg SB, Atmar RL, et al. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA. 2000;283:499-505.
5. Poland GA, Rottinghaus ST, Jacobson RM. Influenza vaccines: a review and rationale for use in developed and underdeveloped countries. Vaccine. 2001;19:2216-2220.
6. Morens DM, Rash VM. Lessons from a nursing home outbreak of influenza A. Infect Control Hosp Epidemiol. 1995;16:275-280.
7. Minino AM, Smith BL. Deaths: preliminary data for 2000. Natl Vital Stat Rep. 2001;49:1-40.
8. Bridges CB, Fukuda K, Uyeki TM, et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2002;51(RR03):1-31.
9. Zimmerman RK. Lowering the age for routine influenza vaccination to 50 years: AAFP leads the nation in influenza vaccine policy. Am Fam Physician. 1999;60:2061-2066.
10. Langmuir AD, Henderson DA, Serfling RE. The epidemiological basis for the control of influenza. Am J Public Health. 1964;54:563-571.
11. Davis MM, McMahon SR, Santoli JM, et al. A national survey of physician practices regarding influenza vaccine. J Gen Intern Med. 2002;17:670-676.
12. Ashby-Hughes B, Nickerson N. Provider endorsement: the strongest cue in prompting high-risk adults to receive influenza and pneumococcal immunizations. Clin Excell Nurse Pract. 1999;3:97-104.
13. Nichol KL. Ten-year durability and success of an organized program to increase influenza and pneumococcal vaccination rates among high-risk adults. Am J Med. 1998;105:385-392.
14. Centers for Disease Control and Prevention. Reasons reported by Medicare beneficiaries for not receiving influenza and pneumococcal vaccinations - United States, 1996. MMWR Morb Mortal Wkly Rep. 1999;48:886-890.
15. Nordin J, Mullooly J, Poblete S, et al. Influenza vaccine effectiveness in preventing hospitalizations and deaths in persons 65 years or older in Minnesota, New York, and Oregon: data from three health plans. J Infect Dis. 2001;184:665-670.
16. Christenson B, Lundbergh P, Hedlund J, Örtqvist Ä. Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in adults aged 65 years or older: a prospective study. Lancet. 2001;357:1008-1011.
17. Nichol KL. Clinical effectiveness and cost effectiveness of influenza vaccination among healthy working adults. Vaccine. 1999;17:S67-S73.
18. Carman WF, Elder AG, Wallace LA, et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet. 2000;355:93-97.